Tempo Bioscience
Developing cell models and assay technologies
Tempo Bioscience
Developing cell models and assay technologies
Founded in 2013, Tempo Bioscience, Inc (Tempo) develops human stem cells (human iPSC technology) based cell models and innovative assay technologies for non-clinical drug development, bioprocessing, in vitro diagnostics, and biomarker development. Our products and services serve as valuable tools for the Biotech-Pharmaceutical industry.
Innovate. Communicate. Respect.
Tempo’s Mission
To improve health by unlocking the power of cells
Tempo Bioscience serves public-private biotech-pharmaceutical entities, academic and non-profit institutions, government laboratories, venture-backed biotech startups, and Fortune 500 companies. Our goal is to advance research and development by empowering scientists with the best cell based technologies.
Awarded in 2018 as the Top 10 Drug Discovery Solution Providers.
Awarded in 2021 as the Top10 Biotech Startup.